These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17284530)

  • 21. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma.
    Amaravadi RK; Yu D; Lum JJ; Bui T; Christophorou MA; Evan GI; Thomas-Tikhonenko A; Thompson CB
    J Clin Invest; 2007 Feb; 117(2):326-36. PubMed ID: 17235397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity.
    Saha MN; Jiang H; Jayakar J; Reece D; Branch DR; Chang H
    Cancer Biol Ther; 2010 Jun; 9(11):936-44. PubMed ID: 20418664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
    Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
    Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
    Fan YH; Cheng J; Vasudevan SA; Dou J; Zhang H; Patel RH; Ma IT; Rojas Y; Zhao Y; Yu Y; Zhang H; Shohet JM; Nuchtern JG; Kim ES; Yang J
    Cell Death Dis; 2013 Oct; 4(10):e867. PubMed ID: 24136231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of p53 DNA binding function by the MDM2 protein acidic domain.
    Cross B; Chen L; Cheng Q; Li B; Yuan ZM; Chen J
    J Biol Chem; 2011 May; 286(18):16018-29. PubMed ID: 21454483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition.
    Nair VD; McNaught KS; González-Maeso J; Sealfon SC; Olanow CW
    J Biol Chem; 2006 Dec; 281(51):39550-60. PubMed ID: 17060322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition.
    Nikiforov MA; Riblett M; Tang WH; Gratchouck V; Zhuang D; Fernandez Y; Verhaegen M; Varambally S; Chinnaiyan AM; Jakubowiak AJ; Soengas MS
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19488-93. PubMed ID: 18042711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant.
    Slatter TL; Hung N; Bowie S; Campbell H; Rubio C; Speidel D; Wilson M; Baird M; Royds JA; Braithwaite AW
    Cell Death Dis; 2015 Jun; 6(6):e1783. PubMed ID: 26068791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.
    Yogev O; Barker K; Sikka A; Almeida GS; Hallsworth A; Smith LM; Jamin Y; Ruddle R; Koers A; Webber HT; Raynaud FI; Popov S; Jones C; Petrie K; Robinson SP; Keun HC; Chesler L
    Cancer Res; 2016 May; 76(10):3025-35. PubMed ID: 27197232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
    Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
    Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts.
    Vater CA; Bartle LM; Dionne CA; Littlewood TD; Goldmacher VS
    Oncogene; 1996 Aug; 13(4):739-48. PubMed ID: 8761295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
    Domostegui A; Peddigari S; Mercer CA; Iannizzotto F; Rodriguez ML; Garcia-Cajide M; Amador V; Diepstraten ST; Kelly GL; Salazar R; Kozma SC; Kusnadi EP; Kang J; Gentilella A; Pearson RB; Thomas G; Pelletier J
    Blood; 2021 Jun; 137(24):3351-3364. PubMed ID: 33512431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
    Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor promotion by Mdm2 splice variants unable to bind p53.
    Fridman JS; Hernando E; Hemann MT; de Stanchina E; Cordon-Cardo C; Lowe SW
    Cancer Res; 2003 Sep; 63(18):5703-6. PubMed ID: 14522887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of p73 promotes dissemination of Myc-induced B cell lymphomas in mice.
    Nemajerova A; Petrenko O; Trümper L; Palacios G; Moll UM
    J Clin Invest; 2010 Jun; 120(6):2070-80. PubMed ID: 20484818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
    Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
    Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.